Skip to content

Clinical trials

Phase 1/2 Uterine Cervical Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 1/2 Country / region: Germany Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20131
20191
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed2
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AGO Study Group1
Bristol-Myers Squibb1
Clovis Oncology, Inc.1
Daiichi Sankyo1
Eli Lilly and Company1
ISA Pharmaceuticals1
Julius-Maximilians University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms7
Ovarian Neoplasms5
Endometrial Neoplasms4
Melanoma3
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Transitional Cell2
Fallopian Tube Neoplasms2
Biliary Tract Neoplasms1
Breast Diseases1
Breast Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.